Ocular Therapeutix announced changes to its leadership and board of directors to strengthen its focus on retina care.
Pravin U. Dugel, MD, was named as executive chairman of the board, Jeffrey S. Heier, MD, as chief scientific officer, Peter K. Kaiser, MD, as medical director, and Sanjay Nayak, MBBS, PhD, as chief strategy officer.
“We are bringing together the ‘Retina Dream Team’ to position Ocular at the forefront of retina care, further energizing the momentum behind the Axpaxli phase 3 wet AMD program,” Antony Mattessich, CEO of Ocular Therapeutix, said (Read more...)